Celebration, FL, July 15, 2025 (GLOBE NEWSWIRE) -- La Rosa Holdings Corp. (NASDAQ: LRHC) (“La Rosa” or the “Company”), a real estate and PropTech company, today announced the launch of its proprietary AI-powered communication bot built specifically to enhance agent recruiting and support operations across its platform.
New regional datacenter strengthens Gainsight’s commitment to EMEA growth, enterprise readiness, and the global deployment of AI-powered customer intelligence
New regional datacenter strengthens Gainsight’s commitment to EMEA growth, enterprise readiness, and the global deployment of AI-powered customer intelligence
BANGALORE, India, July 14, 2025 /PRNewswire/ -- Virtual Lab Software Market is Segmented by Type (On-Premise, Cloud-Based), by Application (Virtual Lab Software Market, Large...
BANGALORE, India, July 14, 2025 /PRNewswire/ -- Virtual Lab Software Market is Segmented by Type (On-Premise, Cloud-Based), by Application (Virtual Lab Software Market, Large...
NOIDA, India, July 10, 2025 /PRNewswire/ -- HCLSoftware, a global leader in enterprise software solutions, announced today the launch of HCL Domino 14.5. Specifically...
Continuing collaboration will utilize the capabilities of the Medidata Data Experience, fostering efficiency, fast-tracking research breakthroughs, and raising the standard of clinical trials
SINGAPORE,...
Continuing collaboration will utilize the capabilities of the Medidata Data Experience, fostering efficiency, fast-tracking research breakthroughs, and raising the standard of clinical trials
SINGAPORE,...
LOS ANGELES, July 8, 2025 /PRNewswire/ -- The push toward more personalized instruction in K–12 classrooms is accelerating, and platforms like edYOU are helping...
In this 2025 product transparency update, BloodVitals details how its pulse oximeter supports real-time blood vitals tracking through non-invasive technology designed for seniors and at-home wellness users. The release explores the shift toward pain-free health monitoring, the rising demand for accessible oxygen level tools, and the increasing role of pulse oximeters in managing vital signs outside clinical settings.
In this 2025 product transparency update, BloodVitals details how its pulse oximeter supports real-time blood vitals tracking through non-invasive technology designed for seniors and at-home wellness users. The release explores the shift toward pain-free health monitoring, the rising demand for accessible oxygen level tools, and the increasing role of pulse oximeters in managing vital signs outside clinical settings.
Basel, July 8, 2025 – Novartis today announced Coartem® (artemether-lumefantrine) Baby has been approved by Swissmedic as the first malaria medicine for newborns and young infants. The new treatment, also known as Riamet® Baby in some countries, was developed in collaboration with Medicines for Malaria Venture (MMV) to treat the potentially deadly mosquito-borne disease.